Brief: Avaí Bio And Austrianova Begin Production Of Master Cell Bank For Klotho Anti-Aging Therapy Under Gmp Standards
03/03/2026 13:31
March 3 (Reuters) - Avai Bio Inc AVAI.PK: AVAÍ BIO AND AUSTRIANOVA BEGIN PRODUCTION OF MASTER CELL BANK FOR KLOTHO ANTI-AGING THERAPY UNDER GMP STANDARDS Source text: ID:nPn6Txzvba Further company coverage: AVAI.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avai Bio
See all newsBrief: Avai Bio, Ainnova Tech terminate JV, license agreement on May 7, 2026 - SEC Filing
Brief: Avaí Bio And Austrianova Begin Production Of Master Cell Bank For Klotho Anti-Aging Therapy Under Gmp Standards
Brief: Avant Technologies And JV Partner, Ainnova, Prepare For Key FDA Milestone With Next Week's Pre-Submission Meeting
Brief: Avant Technologies Signs Letter Of Intent For A Business Combination
Brief: Avant Technologies And Ainnova Tech Begin Acquisition Talks